PPARδ modulates lipopolysaccharide-induced TNFα inflammation signaling in cultured cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 40, Issue 6, 2006, Pages 821-828

  Ding, Guoliang ^a   Cheng, Lihong ^a   Qin, Qianhong ^a   Frontin, Sonya ^a   Yang, Qinglin ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyocytes; Inflammation; NF B; PPAR ; PPAR ligand; TNF

Indexed keywords

ADENOVIRUS VECTOR; GW 0742; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MUTANT PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GW0742; I KAPPA B KINASE; LIGAND; MESSENGER RNA; THIAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; HEART CELL CULTURE; INFLAMMATION; LIGAND BINDING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HEART; HEART MUSCLE CELL; METABOLISM; MOUSE; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CULTURE MEDIA; GENE EXPRESSION REGULATION; HEART; I-KAPPA B KINASE; INFLAMMATION; LIGANDS; LIPOPOLYSACCHARIDES; MICE; MYOCYTES, CARDIAC; NF-KAPPA B; PPAR DELTA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIAZOLES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33744519163     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.03.422     Document Type: Article

References (29)

1. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol 274 (1998) R577-R595
2. Gurevitch J., Frolkis I., Yuhas Y., Lifschitz-Mercer B., Berger E., Paz Y., et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 30 (1997) 1554-1561
3. Takano H., Nagai T., Asakawa M., Toyozaki T., Oka T., Komuro I., et al. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Circ Res 87 (2000) 596-602
4. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16 (1998) 225-260
5. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107 (2001) 241-246
6. Ye P., Fang H., Zhou X., He Y.L., and Liu Y.X. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Chin Med J Sci 19 (2004) 243-247
7. Yamamoto K., Ohki R., Lee R.T., Ikeda U., and Shimada K. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 104 (2001) 1670-1675
8. Maruyama S., Kato K., Kodama M., Hirono S., Fuse K., Nakagawa O., et al. Fenofibrate, a peroxisome proliferator-activated receptor alpha activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats. J Atheroscler Thromb 9 (2002) 87-92
9. Diep Q.N., Benkirane K., Amiri F., Cohn J.S., Endemann D., and Schiffrin E.L. PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats. J Mol Cell Cardiol 36 (2004) 295-304
10. Cheng L., Ding G., Qin Q., Huang Y., Lewis W., He N., et al. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10 (2004) 1245-1250
11. Rival Y., Beneteau N., Taillandier T., Pezet M., Dupont-Passelaigue E., Patoiseau J.F., et al. PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells. Eur J Pharmacol 435 (2002) 143-151
12. Lee C.H., Chawla A., Urbiztondo N., Liao D., Boisvert W.A., Evans R.M., et al. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302 (2003) 453-457
13. Planavila A., Rodriguez-Calvo R., Jove M., Michalik L., Wahli W., Laguna J.C., et al. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc Res 65 (2005) 832-841
14. Cheng L., Ding G., Qin Q., Xiao Y., Woods D., Chen Y.E., et al. Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochem Biophys Res Commun 313 (2004) 277-286
15. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
16. Kubota T., McNamara D.M., Wang J.J., Trost M., McTiernan C.F., Mann D.L., et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. Circulation 97 (1998) 2499-2501
17. McMurray J., Abdullah I., Dargie H.J., and Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 66 (1991) 356-358
18. Mann D.L., and Young J.B. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 105 (1994) 897-904
19. Matsumori A., Yamada T., Suzuki H., Matoba Y., and Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72 (1994) 561-566
20. Habib F.M., Springall D.R., Davies G.J., Oakley C.M., Yacoub M.H., and Polak J.M. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347 (1996) 1151-1155
21. Kapadia S., Lee J., Torre-Amione G., Birdsall H.H., Ma T.S., and Mann D.L. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96 (1995) 1042-1052
22. Kapadia S.R., Oral H., Lee J., Nakano M., Taffet G.E., and Mann D.L. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 81 (1997) 187-195
23. Gulick T., Cresci S., Caira T., Moore D.D., and Kelly D.P. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91 (1994) 11012-11016
24. Watanabe K., Fujii H., Takahashi T., Kodama M., Aizawa Y., Ohta Y., et al. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. J Biol Chem 275 (2000) 22293-22299
25. Gilde A.J., van der Lee K.A., Willemsen P.H., Chinetti G., van der Leij F.R., van der Vusse G.J., et al. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res 92 (2003) 518-524
26. Delerive P., Gervois P., Fruchart J.C., and Staels B. Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J Biol Chem 275 (2000) 36703-36707
27. Delerive P., De Bosscher K., Vanden Berghe W., Fruchart J.C., Haegeman G., and Staels B. DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha. Mol Endocrinol 16 (2002) 1029-1039
28. Westergaard M., Henningsen J., Johansen C., Rasmussen S., Svendsen M.L., Jensen U.B., et al. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol 121 (2003) 1104-1117
29. Planavila A., Laguna J.C., and Vazquez-Carrera M. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem 280 (2005) 17464-17471